Clinical Trials · NCT03672604
A Phase 1 Study to Assess the Safety of NLY01 in Healthy Subjects
- Phase
- Phase 1
- Recruitment status
- Completed
- Sponsor
- Neuraly, Inc.
- Enrollment
- 96
- Start date
- Sep 2018
- Locations
- 1 site, United States
- Primary endpoint
- Treatment-Related Adverse Events